Gilead Sciences Inc. and Emory University, represented by Liza M. Walsh and Eleonore Ofosu-Antwi, have accused Indian drugmaker Hetero Drugs Ltd. of infringing four patents protecting Truvada®, Gilead’s commercially successful HIV treatment. Read…
read moreBy: Marc D. Haefner In a recent opinion, the New Jersey Supreme Court held that trial courts may not “deprive litigants of their right to a jury trial as a…
read moreQuaker Oats to Fight Syrup Claims in Cali Read Full Article Here >
read moreRetirement Plan Can Mandate Arbitration, Cost-Sharing. Read Full Article Here ›
read moreBy: Peter J. Pizzi The New Jersey Truth-in-Consumer Contract, Warranty, and Notice Act (TCCWNA), N.J.S.A. 56:12-14, et seq. went into effect in 1981. After over thirty years on the books,…
read moreBy: Caitlin P. Cascino In a decision announced July 26, 2016, an intermediate appellate court in New Jersey issued a decision upholding a public university’s ability to make disciplinary decisions…
read moreWalsh Cyber Lawyer Peter J. Pizzi, CIPP/US, explains how to find the key items of evidence in a digital morass. For more information, read the full article, or contact Peter at [email protected]…
read moreA veteran of countless federal court pharmaceutical industry wars, Liza M. Walsh formed Walsh to meet client needs for special skills, responsiveness and flexibility. Read Full Article ›
read moreNew Jersey Law Journal placed the founding of Walsh in context with other changes in the legal industry. Read Full Article ›
read moreThe Defend Trade Secrets Act of 2016, signed into law on May 11, 2016, creates federal court jurisdiction and additional remedies for the misappropriation of trade secrets, an area of…
read more